Skip to main content
Top

AIDS and Behavior

Issue 3/2005

Content (12 Articles)

AIDS PUBLIC POLICY FEATURED ARTICLE

Housing Status and HIV Risk Behaviors: Implications for Prevention and Policy

Angela Aidala, Jay E. Cross, Ron Stall, David Harre, Esther Sumartojo

Behavioral Changes in the Era of Combination Therapies

Changes in Attitudes Toward Antiviral Medication: A Comparison of Women Living with HIV/AIDS in the Pre-HAART and HAART Eras

Eric W. Schrimshaw, Karolynn Siegel, Helen-Maria Lekas

Behavioral Changes in the Era of Combination Therapies

Predictors of Serostatus Disclosure to Partners Among Young People Living with HIV in the Pre- and Post-HAART Eras

Philip Batterham, Eric Rice, Mary Jane Rotheram-Borus

BEHAVIORAL CHANGES IN THE ERA OF COMBINATION THERAPIES

Sexual Risk Behavior Among Injection Drug Users Before Widespread Availability of Highly Active Antiretroviral Therapy

Melanie L. Rusch, Homayoon Farzadegan, Patrick M. Tarwater, Mahboobeh Safaeian, David Vlahov, Steffanie A. Strathdee

Behavioral Changes in the Era of Combination Therapies

Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users

Elizabeth T. Golub, Lisa A. Purvis, Marcella Sapun, Mahboobeh Safaeian, Chris Beyrer, David Vlahov, Steffanie A. Strathdee

Interpersonal Violence and Aids

Sexual and Physical Victimization as Predictors of HIV Risk Among Felony Drug Offenders

Steven Belenko, Jeffrey Lin, Lisa O’Connor, Hung-En Sung, Kevin G. Lynch

Interpersonal Violence and HIV/AIDS

The Association of Partner Abuse with Risky Sexual Behaviors Among Women and Men with HIV/AIDS

Laura M. Bogart, Rebecca L. Collins, William Cunningham, Robin Beckman, Daniela Golinelli, David Eisenman, Chloe E. Bird

INTERPERSONAL VIOLENCE AND HIV/AIDS

Increased Risk of HIV in Women Experiencing Physical Partner Violence in Nairobi, Kenya

Karoline Fonck, Leye Els, Nancy Kidula, Jeconiah Ndinya-Achola, Marleen Temmerman

OTHER RESEARCH ARTICLES

Variations in Patterns of Highly Active Antiretroviral Therapy (HAART) Adherence

Andrew J. Levine, Charles H. Hinkin, Steven A. Castellon, Karen I. Mason, Mona N. Lam, Adam Perkins, Marta Robinet, Douglas Longshore, Thomas Newton, Hector Myers, Ramani S. Durvasula, David J. Hardy

OTHER RESEARCH ARTICLES

Elicitation of Salient Beliefs Related to Drug Preparation Practices Among Injection Drug Users in Puerto Rico

Héctor M. Colón, H. Ann Finlinson, Martin Fishbein, Rafaela R. Robles, Mayra Soto-López, Héctor Marcano

OTHER RESEARCH ARTICLES

HIV Transmission Behaviors in Jail/Prison Among Puerto Rican Drug Injectors in New York and Puerto Rico

Sung-Yeon Kang, Sherry Deren, Jonny Andia, Hector M. Colón, Rafaela Robles, Denise Oliver-Velez

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine